| Product Name | Atazanavir-d18 |
| Product Code | DA-A324-11 |
| Chemical name | Atazanavir-d18 |
| Synonyms | (3S,8S,9S,12S)-3,12-Bis[1,1-di(Methyl-d3)ethyl-2,2,2-d3]-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioic acid 1,14-dimethyl ester; methyl ((5S,8S,9S,14S)-8-benzyl-9-hydroxy-15,15-bis(methyl-d3)-5-(2-(methyl-d3)propan-2-yl-1,1,1,3,3,3-d6)-3,6,13-trioxo-11-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,11,12-tetraazahexadecan-14-yl-16,16,16-d3)carbamate; |
| Impurity | NA |
| CAS Number | 1092540-52-7 |
| Alternate CAS # | NA |
| Molecular form | C38H34D18N6O7 |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 722.98 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | stable isotopes,impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals |
| Boiling Point | NA |
| Applications | Atazanavir-d18 is the isotope labelled analog of Atazanavir ; an azapeptide HIV protease inhibitor. Atazanavir has also been investigated as potential treatment of human immunodeficiency virus (HIV) and for anticancer purposes. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
| NA |
